{"id":"https://openalex.org/W1973409404","doi":"https://doi.org/10.1002/1097-0142(19860415)57:8+<1709::aid-cncr2820571315>3.0.co;2-f","title":"Safety and tolerance of recombinant interferon alfa-2a (roferon\u00ae-A) in Cancer Patients","display_name":"Safety and tolerance of recombinant interferon alfa-2a (roferon\u00ae-A) in Cancer Patients","alternate_titles":[],"publication_year":1986,"publication_date":"1986-04-15","ids":{"openalex":"https://openalex.org/W1973409404","doi":"https://doi.org/10.1002/1097-0142(19860415)57:8+<1709::aid-cncr2820571315>3.0.co;2-f","mag":"1973409404","pmid":"https://pubmed.ncbi.nlm.nih.gov/3948143"},"language":"en","primary_location":{"id":"doi:10.1002/1097-0142(19860415)57:8+<1709::aid-cncr2820571315>3.0.co;2-f","doi":"https://doi.org/10.1002/1097-0142(19860415)57:8+<1709::aid-cncr2820571315>3.0.co;2-f","is_oa":false,"landing_page_url":"https://doi.org/10.1002/1097-0142(19860415)57:8+<1709::aid-cncr2820571315>3.0.co;2-f","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1973409404"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Gary J. Jones","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gary J. Jones","raw_affiliation_strings":["Department of Clinical Oncology, Clinical Research and Development, Hoffmann-La Roche Inc. Nutley, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, Clinical Research and Development, Hoffmann-La Roche Inc. Nutley, New Jersey","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061549536","display_name":"Loretta Marie Itri","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Loretta M. Itri","raw_affiliation_strings":["Department of Clinical Oncology, Clinical Research and Development, Hoffmann-La Roche Inc. Nutley, New Jersey","Hoffmann\u2010La Roche Inc. Building 115/5340 Kingsland Street, Nutley, NJ 07110"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, Clinical Research and Development, Hoffmann-La Roche Inc. Nutley, New Jersey","institution_ids":[]},{"raw_affiliation_string":"Hoffmann\u2010La Roche Inc. Building 115/5340 Kingsland Street, Nutley, NJ 07110","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5061549536"],"corresponding_institution_ids":[],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":4.3291,"has_fulltext":false,"cited_by_count":174,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.95173821,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"57","issue":"S8","first_page":"1709","last_page":"1715"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.26339998841285706,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.26339998841285706,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.1289999932050705,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.1136000007390976,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interferon-alfa-2a","display_name":"interferon alfa-2a","score":0.9929999709129333},{"id":"https://openalex.org/keywords/cancer-patients","display_name":"cancer patients","score":0.5550000071525574},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.8460000157356262},{"id":"https://openalex.org/keywords/drug-tolerance","display_name":"drug tolerance","score":0.6320000290870667},{"id":"https://openalex.org/keywords/dose-attenuation","display_name":"dose attenuation","score":0.6679999828338623},{"id":"https://openalex.org/keywords/acute-toxicity","display_name":"acute toxicity","score":0.652999997138977},{"id":"https://openalex.org/keywords/fever-and-chills","display_name":"fever and chills","score":0.7929999828338623},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.4690000116825104},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.7910000085830688},{"id":"https://openalex.org/keywords/liver-dysfunction","display_name":"liver dysfunction","score":0.6769999861717224},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.8399999737739563},{"id":"https://openalex.org/keywords/neurologic-toxicity","display_name":"neurologic toxicity","score":0.9449999928474426},{"id":"https://openalex.org/keywords/anti-interferon-antibodies","display_name":"anti-interferon antibodies","score":0.7990000247955322},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.8240000009536743},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.9179999828338623},{"id":"https://openalex.org/keywords/intramuscular-injection","display_name":"intramuscular injection","score":0.7360000014305115}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9343052506446838},{"id":"https://openalex.org/C2778594517","wikidata":"https://www.wikidata.org/wiki/Q2260058","display_name":"Chills","level":2,"score":0.7891378402709961},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7434214949607849},{"id":"https://openalex.org/C2778616394","wikidata":"https://www.wikidata.org/wiki/Q474959","display_name":"myalgia","level":2,"score":0.6671944856643677},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.638225793838501},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6209556460380554},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.597000241279602},{"id":"https://openalex.org/C2778654693","wikidata":"https://www.wikidata.org/wiki/Q254327","display_name":"Anorexia","level":2,"score":0.48945489525794983},{"id":"https://openalex.org/C2780873365","wikidata":"https://www.wikidata.org/wiki/Q496812","display_name":"Leukopenia","level":3,"score":0.4643329381942749},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4531545639038086},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.424147367477417},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.40835556387901306},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3467382788658142}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000917","descriptor_name":"Antibody Formation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007370","descriptor_name":"Interferon Type I","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007370","descriptor_name":"Interferon Type I","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007370","descriptor_name":"Interferon Type I","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/1097-0142(19860415)57:8+<1709::aid-cncr2820571315>3.0.co;2-f","doi":"https://doi.org/10.1002/1097-0142(19860415)57:8+<1709::aid-cncr2820571315>3.0.co;2-f","is_oa":false,"landing_page_url":"https://doi.org/10.1002/1097-0142(19860415)57:8+<1709::aid-cncr2820571315>3.0.co;2-f","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:3948143","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3948143","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W1501348451","https://openalex.org/W1568595855","https://openalex.org/W1765288714","https://openalex.org/W1875354643","https://openalex.org/W1963674925","https://openalex.org/W1979116217","https://openalex.org/W1991295994","https://openalex.org/W1998009728","https://openalex.org/W2003004828","https://openalex.org/W2020089973","https://openalex.org/W2030124997","https://openalex.org/W2034489572","https://openalex.org/W2037650318","https://openalex.org/W2052677652","https://openalex.org/W2058870577","https://openalex.org/W2060441546","https://openalex.org/W2060926084","https://openalex.org/W2061785757","https://openalex.org/W2064447898","https://openalex.org/W2080484471","https://openalex.org/W2089433411","https://openalex.org/W2091462490","https://openalex.org/W2093344226","https://openalex.org/W2110489989","https://openalex.org/W2128394628","https://openalex.org/W2144360148","https://openalex.org/W2235894312","https://openalex.org/W2306809556","https://openalex.org/W2307147645","https://openalex.org/W2339932366","https://openalex.org/W2344245690","https://openalex.org/W2395748156","https://openalex.org/W2412626481","https://openalex.org/W2413806782","https://openalex.org/W2415478501","https://openalex.org/W2417072489","https://openalex.org/W2470250129","https://openalex.org/W4232333904","https://openalex.org/W4233634731"],"related_works":["https://openalex.org/W1967966019","https://openalex.org/W2291101679","https://openalex.org/W3122717601","https://openalex.org/W1891921601","https://openalex.org/W2104332441","https://openalex.org/W2030207881","https://openalex.org/W2086172507","https://openalex.org/W2027898486","https://openalex.org/W2173422486","https://openalex.org/W2094353318"],"abstract_inverted_index":{"Recombinant":[0],"interferon":[1],"alfa-2a":[2],"(Roferon-A,":[3],"Hoffmann-La":[4],"Roche":[5],"Inc.,":[6],"Nutley,":[7],"NJ)":[8],"has":[9],"been":[10,248],"evaluated":[11],"in":[12,68,105,171,207],"clinical":[13,128,245],"trials":[14],"of":[15,24,108,122,139,163,229,233],"more":[16],"than":[17],"1300":[18],"patients":[19,112,132,235],"with":[20,28,37,134,153,160,250],"a":[21],"broad":[22],"spectrum":[23],"oncologic":[25],"disease.":[26],"Patients":[27],"either":[29],"solid":[30],"tumors":[31],"or":[32,39,227],"hematologic":[33],"malignancies":[34],"were":[35,211,221],"treated":[36,133],"daily":[38,70],"three-times-weekly":[40,89],"intramuscular":[41],"injections":[42],"for":[43],"induction":[44],"periods":[45],"ranging":[46],"from":[47,54],"8":[48],"to":[49,59,88,99,120,126,238,253],"16":[50],"weeks.":[51],"Doses":[52],"ranged":[53],"1":[55],"X":[56,61,74],"10(6)":[57,62,75],"units":[58,63],"124":[60],"per":[64],"injection.":[65],"When":[66],"administered":[67],"low":[69],"doses":[71,115],"(approximately":[72],"3":[73],"units),":[76],"Roferon-A":[77,135],"was":[78,84,96,168],"well":[79],"tolerated,":[80],"and":[81,156,185,193,205],"dose":[82,95,118,125,217,225],"attenuation":[83,119],"rarely":[85,215],"required.":[86],"Change":[87],"treatment":[90],"regimen":[91],"at":[92,200],"the":[93,123,164],"same":[94],"usually":[97,151,222],"sufficient":[98],"control":[100],"toxicity":[101,141,195,204],"when":[102],"it":[103],"occurred":[104,152,197],"this":[106],"group":[107],"low-dose":[109],"patients.":[110],"Those":[111],"receiving":[113],"higher":[114,201],"frequently":[116,157],"required":[117,216],"50%":[121],"starting":[124],"improve":[127],"tolerance.":[129],"Virtually":[130],"all":[131,234],"experienced":[136],"some":[137],"degree":[138],"acute":[140],"manifested":[142],"as":[143],"fever,":[144],"chills,":[145],"myalgia,":[146],"and/or":[147],"headache.":[148],"These":[149],"reactions":[150,190],"initial":[154],"dosing":[155,181],"improved":[158],"spontaneously":[159],"continued":[161],"administration":[162],"drug.":[165],"Acetaminophen":[166],"pretreatment":[167],"generally":[169],"useful":[170],"ameliorating":[172],"these":[173],"symptoms.":[174],"Common":[175],"adverse":[176,189,244],"experiences":[177],"occurring":[178],"after":[179,224],"repeated":[180],"included":[182],"fatigue,":[183],"anorexia,":[184],"weight":[186],"loss.":[187],"Serious":[188],"including":[191],"cardiovascular":[192],"neurologic":[194],"have":[196,247],"infrequently,":[198],"primarily":[199],"doses.":[202],"Hematologic":[203],"elevations":[206],"liver":[208],"function":[209],"parameters":[210],"also":[212],"observed,":[213],"but":[214],"attenuation.":[218],"Adverse":[219],"effects":[220],"reversible":[223],"reduction":[226],"discontinuation":[228],"therapy.":[230],"Approximately":[231],"27%":[232],"developed":[236],"antibodies":[237],"rHuIFN-alpha":[239],"2A":[240],"during":[241],"treatment.":[242],"No":[243],"sequelae":[246],"associated":[249],"antibody":[251],"development":[252],"date.":[254]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1973409404","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
